Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group
-
Published:2024-08
Issue:3
Volume:3
Page:100283
-
ISSN:2772-8293
-
Container-title:Journal of Allergy and Clinical Immunology: Global
-
language:en
-
Short-container-title:Journal of Allergy and Clinical Immunology: Global
Author:
Alexander Tobias,
Tassy Noëlle,
Domenech Ariadna,
Kramer Ellen,
Jessop Helen,
Kenyon Michelle,
Sharrack Basil,
Saccardi Riccardo,
Bolanos Natacha,
Snowden John A.,
Greco RaffaellaORCID
Reference25 articles.
1. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT);Alexander;Bone Marrow Transplant,2022
2. Everyday miracles: curing multiple sclerosis, scleroderma, and autoimmune diseases by hematopoietic stem cell transplant;Burt,2022
3. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention;Miller;Curr Opin Immunol,2023
4. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040;Li;Autoimmun Rev,2023
5. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022;Snowden;Bone Marrow Transplant,2022